Julian Baker, Director, 10% Owner at Prelude Therapeutics Inc (PRLD), bought 166,666 shares at $60.00 ($10.0M) on 2021-01-11, disclosed to the SEC on 2021-01-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.00 | 12,444 | $747K | 7.5% |
| 2 | $60.00 | 154,222 | $9.3M | 92.5% |
| Total | $60.00 avg | 166,666 | $10.0M | 100% |
| Filing → |
| MDGL | BUY | 2023-11-15 | $15.6M | — | Filing → |
| BCEL | SELL | 2023-10-23 | $211K | — | Filing → |
| IGMS | BUY | 2023-06-28 | $45.0M | — | Filing → |